Texas Breast Specialists

What Texas Breast Specialists does

Texas Breast Specialists is a specialty division within Texas Oncology, a private, Dallas-based healthcare organization that operates more than 250 locations across Texas staffed by over 550 physicians. The division is dedicated to diagnosing and treating diseases and disorders of the breast, serving two patient segments: women with breast cancer (primary) and women with benign breast conditions. Service offerings span the full care continuum—radiology, breast surgery (lumpectomy, mastectomy, sentinel lymph node biopsy), oncoplastic and reconstructive surgery, chemotherapy, immunotherapy, precision medicine, radiation therapy, robotic-assisted surgery, and survivorship support. The business model is professional-services fee-for-service billed through insurance (Medicare, Medicaid, and commercial plans), with pricing not publicly disclosed and patient-specific estimates provided via financial counselors after benefit verification. Distribution occurs through the Texas Oncology clinic network, referral relationships, and direct patient self-referrals, with hospital-based care enabled through a partnership with Memorial Hermann.

The underlying technology stack is clinical rather than digital: integrated diagnostic imaging, surgical technology, and treatment delivery (including proton therapy at the Texas Center for Proton Therapy and HIPEC cytoreductive surgery) underwritten by participation in the Sarah Cannon Research Institute clinical trials program. Digital touchpoints are limited to a Navigating Care patient portal and the Careopolis invitation-only community platform with blog, calendar, photo-sharing, and 3D medical animation features; no public API, SDK, or mobile app is offered. Patient forms are PDF-only, and there is no evidence of AI/ML capabilities in the disclosed product surface. The division operates as a component of Texas Oncology's broader oncology franchise, which includes medical, radiation, and surgical oncology, blood & marrow transplant, gynecologic oncology, and hematology programs, and is part of The US Oncology Network for administrative and operational infrastructure.

Name

Texas Breast Specialists

Legal name

Texas Oncology

Website

https://texasbreastspecialists.com

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

11–50 employees

Short description

Texas Breast Specialists is a specialty division within Texas Oncology providing comprehensive breast care—diagnosis, surgery, chemotherapy, radiation, and clinical trials—to women across Texas through 250+ locations and 550+ physicians.

Ownership category

akta.pro rank

Product category

Oncology Services

NAICS

Offices of Physicians (except Mental Health Specialists) (621111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Breast Oncology (HLAKAFAJ)

akta.pro secondary industry

Women’s Imaging & Breast Health Centers (HLAFAJAJ)

Keywords

• Breast cancer care
• Oncology services
• Breast surgery
• Cancer treatment
• Clinical trials

Headquarters

HQ city

Amarillo

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure

Revenue model

1. Medical Services Revenue: Revenue generated from diagnostic, surgical, and treatment services for breast conditions including benign breast disease and breast cancer. Services include consultations, procedures, chemotherapy, immunotherapy, and follow-up care delivered through Texas Oncology affiliated practices.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Texas Breast Specialists is a specialty division diagnosing and treating breast diseases and disorders, including benign breast conditions and breast cancer. The division delivers comprehensive breast care spanning imaging/diagnostics, surgery (including reconstructive and oncoplastic procedures), chemotherapy, radiation, immunotherapy, precision medicine, proton therapy, robotic surgery, and HIPEC with cytoreductive surgery, along with access to clinical trials.

Product overview

Texas Breast Specialists is a specialty division within Texas Oncology offering a comprehensive, multi-modality approach to breast healthcare. The core offering is Texas Breast Specialists itself, which provides diagnostic and treatment services for benign breast conditions and breast cancer through a team of radiologists, surgeons, medical oncologists, and other breast specialists. Services span the full continuum of care including breast surgery (lumpectomy, mastectomy, skin-sparing mastectomy), breast reconstructive surgery, chemotherapy, immunotherapy, precision medicine, and access to clinical trials. Texas Breast Specialists operates as part of the broader Texas Oncology network of over 250 locations across Texas, with support services including patient registration forms, Careopolis (online patient community), and patient portal access. The organization also offers specialized surgical oncology services including robotic surgery, HIPEC with cytoreductive surgery, and proton therapy through affiliated centers.

Differentiator

Problem solved

Functional benefit

Products and services

• Breast Surgery Surgical treatment of breast cancer and benign breast disease, including oncoplastic and breast-conserving surgical approaches for patients in Texas.
• Breast Reconstructive Surgery Reconstructive surgical procedures for breast cancer patients undergoing mastectomy or lumpectomy, restoring breast form and appearance.
• Chemotherapy Medical oncology infusion therapy delivered to breast cancer patients within Texas Oncology clinics.
• Radiation Therapy Radiation oncology treatment for breast cancer patients, provided through the Texas Oncology network.
• Immunotherapy Immune-based systemic therapy offered to eligible breast cancer patients within the practice.
• Precision Medicine Genomic and biomarker-driven treatment planning for breast cancer, enabling targeted therapy selection based on tumor molecular profile.
• Proton Therapy Advanced proton-based radiation therapy for select breast cancer cases within the Texas Oncology network.
• Robotic Surgery Robot-assisted surgical procedures used in breast cancer and related surgical care.
• HIPEC with Cytoreductive Surgery Hyperthermic Intraperitoneal Chemotherapy combined with cytoreductive surgery, offered for advanced/metastatic disease management.
• Clinical Trials Program Research program providing breast cancer patients access to investigational therapies and clinical trial enrollment through the Texas Oncology research network.
• Patient Portal Online portal for patients to schedule appointments, pay bills, and access medical records.
• Careopolis Online care coordination and social support platform for breast cancer patients, families, and caregivers.

Quantifiable outcome

• More than 100 FDA-approved cancer therapies developed through clinical trials participation
• +2 more outcomes

Named customers4 records

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Three partnerships are on record, tiered core.

• Sarah Cannon Research Institute (SCRI)coreStrategic or Co-development PartnerTexas Oncology offers clinical trials through Sarah Cannon Research Institute, one of the world's leading oncology research organizations conducting community-based clinical trials. SCRI has contributed to pivotal research that led to the majority of new cancer therapies approved by the FDA.
• Memorial HermanncoreStrategic or Co-development PartnerPartnership enables patients to be seen by Texas Oncology providers through Memorial Hermann's network. Patient Michelle Prescott was diagnosed and treated through this partnership at Memorial Hermann hospital.
• The US Oncology NetworkcoreStrategic or Co-development PartnerTexas Oncology is part of The US Oncology Network. The copyright agent for Texas Oncology can be reached via The US Oncology Network at The Woodlands, TX address.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• The US Oncology Network: National network of community oncology practices that includes Texas Oncology. Directly comparable through shared infrastructure, payer relationships, clinical research programs, and operational support models for community-based specialty cancer care.
• Tennessee Oncology: Community-based oncology practice providing specialty cancer care across Tennessee and a member of the OneOncology network. Comparable in its physician-led model, multi-site community delivery, and breadth of oncology specialties including breast care.
• Florida Cancer Specialists & Research Institute: One of the largest independent community oncology practices in the US, operating across Florida with a similar model of physician-led specialty cancer care, including breast oncology, clinical trials, and community-based delivery at multi-site scale.
• Regional Cancer Care Associates: Multi-state community oncology practice providing physician-led specialty cancer care across the Northeast US. Comparable in business model with community-based delivery, clinical research participation, and comprehensive oncology services.
• Maryland Oncology Hematology: Community oncology practice providing specialty cancer care in the Mid-Atlantic region and a member of The US Oncology Network. Directly comparable peer within the same parent network, sharing physician-led multi-site community delivery.
• New York Cancer & Blood Specialists: Large community oncology practice across New York offering physician-led specialty cancer care including breast oncology. Comparable in scale and multi-site community delivery model.

Broad incumbents

• MD Anderson Cancer Center: World-leading academic cancer center located in Houston, Texas. Overlaps in breast cancer treatment and represents the premier research-driven alternative for high-acuity cases in the same geography.
• Memorial Sloan Kettering Cancer Center: Premier US academic cancer center providing comprehensive oncology care including breast oncology. Broad incumbent with overlapping services and research-driven specialty care, though primarily academic rather than community-based delivery.
• Dana-Farber Cancer Institute: Harvard-affiliated comprehensive cancer center providing specialty oncology care including breast oncology. Comparable in offering leading-edge treatment and clinical trials, but operates in academic medical center model rather than community delivery.

Others

• Sarah Cannon Research Institute: One of the world's leading oncology research organizations and Texas Oncology's clinical trials partner. Comparable through community-based clinical trial programs and contribution to FDA-approved therapies, though focused on research rather than direct patient care delivery.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Instagraminstagram.com/texas.oncology
• LinkedInlinkedin.com/company/texas-breast-specialists

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Texas Breast Specialists